Patents by Inventor Kai Lovis

Kai Lovis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7067683
    Abstract: This invention describes a safe method for the production of sulfamoyl chloride from chlorosulfonyl isocyanate and formic acid in the presence of a amide catalyst, taming the hazardous nature of this reaction by circumventing heat accumulation processes, as well as the sulfamoylation of alcohols and phenols with the resulting sulfamoyl chloride in N,N-dimethyl acetamide or N-methyl pyrrolidone thereby avoiding the formation of side-products which were inevitable with the methods of the prior art using dimethyl formamide or dichloromethane as a solvent. The current invention allows industrial scale applications and describes as an example the process of manufacture of the biologically active compound 17?-Hydroxyestra-1,3,5(10)-triene-3-yl sulfamate.
    Type: Grant
    Filed: December 23, 2002
    Date of Patent: June 27, 2006
    Assignee: Schering AG
    Inventors: Jens Geisler, Frank Schneider, Fernando Lopez Holguin, Kai Lovis
  • Patent number: 6652782
    Abstract: The invention relates to a multi-stage method for producing gas-filled microcapsules. In one stage of the method, the substance that forms the coat is polymerized. The microcapsules are formed in a physically and/or temporally separate stage, by means of a structuring process. The polymerization is carried out with moderate stirring, while the microcapsules are structured in dispersing conditions.
    Type: Grant
    Filed: March 27, 2002
    Date of Patent: November 25, 2003
    Assignee: Schering Aktiengesellschaft
    Inventors: Uwe Budde, Andreas Briel, Georg Rossling, Kai Lovis, Wolfgang Schmidt, Hans-Ulrich Moritz, Michael Gottfried, Jan-Peter Ingwersen
  • Publication number: 20030171346
    Abstract: This invention describes a safe method for the production of sulfamoyl chloride from chlorosulfonyl isocyanate and formic acid in the presence of a amide catalyst, taming the hazardous nature of this reaction by circumventing heat accumulation processes, as well as the sulfamoylation of alcohols and phenols with the resulting sulfamoyl chloride in N,N-dimethyl acetamide or N-methyl pyrrolidone thereby avoiding the formation of side-products which were inevitable with the methods of the prior art using dimethyl formamide or dichloromethane as a solvent. The current invention allows industrial scale applications and describes as an example the process of manufacture of the biologically active compound 17&bgr;-Hydroxyestra-1,3,5(10)-triene-3-yl sulfamate.
    Type: Application
    Filed: December 23, 2002
    Publication date: September 11, 2003
    Applicant: Schering AG
    Inventors: Jens Geisler, Frank Schneider, Fernando Lopez Holguin, Kai Lovis